121 related articles for article (PubMed ID: 32529740)
21. Prolonged cardiac xenograft survival in guinea pig-to-rat model by a highly active cobra venom factor.
Sun QY; Chen G; Guo H; Chen S; Wang WY; Xiong YL
Toxicon; 2003 Sep; 42(3):257-62. PubMed ID: 14559076
[TBL] [Abstract][Full Text] [Related]
22. The role of natural IgM in the hyperacute rejection of discordant heart xenografts.
Gambiez L; Salame E; Chereau C; Calmus Y; Cardoso J; Ayani E; Houssin D; Weill B
Transplantation; 1992 Oct; 54(4):577-83. PubMed ID: 1412747
[TBL] [Abstract][Full Text] [Related]
23. A novel recombinant fibrinogenase of Agkistrodon acutus venom protects against hyperacute rejection via degradation of complements.
Lin X; Qi JZ; Chen MH; Qiu BT; Huang ZH; Qiu PX; Chen JS; Yan GM
Biochem Pharmacol; 2013 Mar; 85(6):772-9. PubMed ID: 23178656
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival.
Davis EA; Lam TT; Qian Z; Ibrahim S; Baldwin WM; Sanfilippo FP
J Heart Lung Transplant; 1995; 14(5):973-80. PubMed ID: 8800736
[TBL] [Abstract][Full Text] [Related]
25. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H
Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695
[TBL] [Abstract][Full Text] [Related]
26. Hypodermin A, a new inhibitor of human complement for the prevention of xenogeneic hyperacute rejection.
Malassagne B; Regimbeau JM; Taboit F; Troalen F; Chéreau C; Moiré N; Attal J; Batteux F; Conti F; Calmus Y; Houssin D; Boulard C; Houdebine LM; Weill B
Xenotransplantation; 2003 May; 10(3):267-77. PubMed ID: 12694547
[TBL] [Abstract][Full Text] [Related]
27. Beyond hyperacute rejection. Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets.
Fryer JP; Leventhal JR; Dalmasso AP; Chen S; Simone PA; Goswitz JJ; Reinsmoen NL; Matas AJ
Transplantation; 1995 Jan; 59(2):171-6. PubMed ID: 7839436
[TBL] [Abstract][Full Text] [Related]
28. Prolonged discordant xenograft survival by inhibition of the intrinsic coagulation pathway in complement C6-deficient recipients.
Jakobs FM; Davis EA; White T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 Mar; 17(3):306-11. PubMed ID: 9563608
[TBL] [Abstract][Full Text] [Related]
29. TMVA, a novel GPIb-binding protein, significantly prevents platelet microthrombi formation and prolongs discordant cardiac xenograft survival.
Chen G; Wei Q; Wang XM; Wang WY; Xiong YL; Chen S
Xenotransplantation; 2004 Mar; 11(2):203-9. PubMed ID: 14962282
[TBL] [Abstract][Full Text] [Related]
30. Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models.
Fiorante P; Banz Y; Mohacsi PJ; Kappeler A; Wuillemin WA; Macchiarini P; Roos A; Daha MR; Schaffner T; Haeberli A; Mazmanian GM; Rieben R
Xenotransplantation; 2001 Feb; 8(1):24-35. PubMed ID: 11208188
[TBL] [Abstract][Full Text] [Related]
31. Functional activity of anti-C6 antibodies elicited in C6-deficient rats reconstituted by liver allografts. Ability to inhibit hyperacute rejection of discordant cardiac xenografts.
Brauer RB; Baldwin WM; Wang D; Pruitt SK; Klein AS; Sanfilippo F
Transplantation; 1996 Feb; 61(4):588-94. PubMed ID: 8610386
[TBL] [Abstract][Full Text] [Related]
32. Normal human immunoglobulins for intravenous use (IVIg) delay hyperacute xenograft rejection through F(ab')2-mediated anti-complement activity.
Latremouille C; Genevaz D; Hu MC; Schussler O; Goussef N; Mandet C; Bruneval P; Haeffner-Cavaillon N; Carpentier A; Glotz D
Clin Exp Immunol; 1997 Oct; 110(1):122-6. PubMed ID: 9353158
[TBL] [Abstract][Full Text] [Related]
33. Human thrombomodulin regulates complement activation as well as the coagulation cascade in xeno-immune response.
Kim H; Hawthorne WJ; Kang HJ; Lee YJ; Hwang JI; Hurh S; Ro H; Jeong JC; Cho B; Yang J; Ahn C
Xenotransplantation; 2015; 22(4):260-72. PubMed ID: 26179123
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species.
Zehr KJ; Herskowitz A; Lee PC; Kumar P; Gillinov AM; Baumgartner WA
Transplantation; 1994 Mar; 57(6):900-6. PubMed ID: 8154039
[TBL] [Abstract][Full Text] [Related]
35. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.
Kang HJ; Lee G; Kim JY; Lee SH; Wi HC; Hwang PG; Chung DH; Kim YT
Eur J Cardiothorac Surg; 2005 Jul; 28(1):149-56. PubMed ID: 15982598
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cell- and macrophage mediated discordant guinea pig-->rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity.
Xia G; Ji P; Rutgeerts O; Waer M
Transplantation; 2000 Jul; 70(1):86-93. PubMed ID: 10919580
[TBL] [Abstract][Full Text] [Related]
37. Key role of the alternate complement pathway in hyperacute rejection of rat hearts transplanted into fetal sheep.
Rajasinghe HA; Reddy VM; Hancock WW; Sayegh MH; Hanley FL
Transplantation; 1996 Aug; 62(3):407-11. PubMed ID: 8779691
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival of hamster hearts in presensitized rats.
Lin Y; Soares MP; Sato K; Csizmadia E; Robson SC; Smith N; Bach FH
J Immunol; 2000 May; 164(9):4883-92. PubMed ID: 10779798
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of cardiac function of discordant heart xenografts using a blood-perfused, isolated, supported heart model].
Miyatake T
Hokkaido Igaku Zasshi; 1994 Jan; 69(1):35-45. PubMed ID: 8119656
[TBL] [Abstract][Full Text] [Related]
40. Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation.
Anderson JB; Smith SA; van Wijk R; Chien S; Kotwal GJ
Transpl Immunol; 2003; 11(2):129-35. PubMed ID: 12799195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
